BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32988965)

  • 21. Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter study.
    Liu T; Dong D; Zhao X; Ou XM; Yi JL; Guan J; Zhang Y; Xiao-Fei L; Xie CM; Luo DH; Sun R; Chen QY; Xing L; Guo SS; Liu LT; Lin DF; Chen YZ; Lin JY; Luo MJ; Yan WB; He ML; Mao MY; Zhu MY; Chen WH; Shen BW; Wang SQ; Li HL; Zhong LZ; Hu CS; Wu DH; Mai HQ; Tian J; Tang LQ
    BMC Med; 2023 Nov; 21(1):464. PubMed ID: 38012705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ΔNp63α is a super enhancer-enriched master factor controlling the basal-to-luminal differentiation transcriptional program and gene regulatory networks in nasopharyngeal carcinoma.
    Cai J; Chen S; Yi M; Tan Y; Peng Q; Ban Y; Yang J; Li X; Zeng Z; Xiong W; McCarthy JB; Li G; Li X; Xiang B
    Carcinogenesis; 2020 Sep; 41(9):1282-1293. PubMed ID: 31826234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of circulating tumor cells and Epstein-Barr virus DNA to progression-free survival and overall survival in metastatic nasopharyngeal carcinoma patients.
    You R; Liu YP; Lin M; Huang PY; Tang LQ; Zhang YN; Pan Y; Liu WL; Guo WB; Zou X; Zhao KM; Kang T; Liu LZ; Lin AH; Hong MH; Mai HQ; Zeng MS; Chen MY
    Int J Cancer; 2019 Nov; 145(10):2873-2883. PubMed ID: 31044420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circular RNA TGFBR2 acts as a ceRNA to suppress nasopharyngeal carcinoma progression by sponging miR-107.
    Li W; Lu H; Wang H; Ning X; Liu Q; Zhang H; Liu Z; Wang J; Zhao W; Gu Y; Li H; Sun X; Hu L; Wang D
    Cancer Lett; 2021 Feb; 499():301-313. PubMed ID: 33160003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deficiency in expression and epigenetic DNA Methylation of ASS1 gene in nasopharyngeal carcinoma: negative prognostic impact and therapeutic relevance.
    Lan J; Tai HC; Lee SW; Chen TJ; Huang HY; Li CF
    Tumour Biol; 2014 Jan; 35(1):161-9. PubMed ID: 23897555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study.
    Voss MH; Reising A; Cheng Y; Patel P; Marker M; Kuo F; Chan TA; Choueiri TK; Hsieh JJ; Hakimi AA; Motzer RJ
    Lancet Oncol; 2018 Dec; 19(12):1688-1698. PubMed ID: 30416077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High SRC-1 and Twist1 expression predicts poor prognosis and promotes migration and invasion by inducing epithelial-mesenchymal transition in human nasopharyngeal carcinoma.
    Zhou J; Zhang J; Xu M; Ke Z; Zhang W; Mai J
    PLoS One; 2019; 14(4):e0215299. PubMed ID: 30973923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
    Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
    Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long Noncoding RNA Expression Signatures of Metastatic Nasopharyngeal Carcinoma and Their Prognostic Value.
    Zhang W; Wang L; Zheng F; Zou R; Xie C; Guo Q; Hu Q; Chen J; Yang X; Yao H; Song E; Xiang Y
    Biomed Res Int; 2015; 2015():618924. PubMed ID: 26448942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of chromosome 14 open reading frame 166 correlates with disease progression and poorer prognosis in human NPC.
    Yang L; Li F; Lei F; Wang Y; Wu S; Song L; Chen Y
    Tumour Biol; 2015 Sep; 36(10):7977-86. PubMed ID: 25964093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival impact of radiotherapy interruption in nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data intelligence platform-based analysis.
    Yao JJ; Zhang F; Gao TS; Zhang WJ; Lawrence WR; Zhu BT; Zhou GQ; Ma J; Wang SY; Sun Y
    Radiother Oncol; 2019 Mar; 132():178-187. PubMed ID: 30448002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinoma.
    Zhang W; Huang C; Gong Z; Zhao Y; Tang K; Li X; Fan S; Shi L; Li X; Zhang P; Zhou Y; Huang D; Liang F; Zhang X; Wu M; Cao L; Wang J; Li Y; Xiong W; Zeng Z; Li G
    J Mol Histol; 2013 Oct; 44(5):545-54. PubMed ID: 23529758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma.
    Wen W; Mai SJ; Lin HX; Zhang MY; Huang JL; Hua X; Lin C; Long ZQ; Lu ZJ; Sun XQ; Liu SL; Yang Q; Zhu Q; Wang HY; Guo L
    J Transl Med; 2019 Jun; 17(1):186. PubMed ID: 31159814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pretreatment MRI radiomics analysis allows for reliable prediction of local recurrence in non-metastatic T4 nasopharyngeal carcinoma.
    Zhang LL; Huang MY; Li Y; Liang JH; Gao TS; Deng B; Yao JJ; Lin L; Chen FP; Huang XD; Kou J; Li CF; Xie CM; Lu Y; Sun Y
    EBioMedicine; 2019 Apr; 42():270-280. PubMed ID: 30928358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of tumor downstaging after neoadjuvant chemotherapy with survival in patients with locally advanced nasopharyngeal carcinoma: a retrospective cohort study.
    Wang W; Peng S; Wu H; Luo Y; Yuan F; Lin Z; Cheng G; Chen S
    J Cancer Res Clin Oncol; 2021 Oct; 147(10):2913-2922. PubMed ID: 34160678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic characterization reveals potential biomarkers in nasopharyngeal carcinoma patients with relapse.
    Cho WCS; Tse KP; Ngan RKC; Cheuk W; Ma VWS; Yang YT; Yip TTC; Tan KT; Chen SJ
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1149-1159. PubMed ID: 33040630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excessive vitamin B6 during treatment is related to poor prognosis of patients with nasopharyngeal carcinoma: A U-shaped distribution suggests low dose supplement.
    Li H; Chen M; Liang S; Wei X; Wang R; Cui C; Ruan G; Ou Q; Liu L
    Clin Nutr; 2021 Apr; 40(4):2293-2300. PubMed ID: 33873269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA HCG18 contributes to nasopharyngeal carcinoma development by modulating miR-140/CCND1 and Hedgehog signaling pathway.
    Li L; Ma TT; Ma YH; Jiang YF
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10387-10399. PubMed ID: 31841193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combining pretreatment plasma Epstein-Barr virus DNA level and cervical node necrosis improves prognostic stratification in patients with nasopharyngeal carcinoma: A cohort study.
    Du YY; Luo DH; Sun XS; Tang LQ; Mai HQ; Chen QY; Zhong JH; Mai DM; Zhang WR; Chen WH; Mo HY
    Cancer Med; 2019 Nov; 8(16):6841-6852. PubMed ID: 31513364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of tumor-infiltrating lymphocytes in nondisseminated nasopharyngeal carcinoma: A large-scale cohort study.
    Wang YQ; Chen YP; Zhang Y; Jiang W; Liu N; Yun JP; Sun Y; He QM; Tang XR; Wen X; Yang XJ; Zhang PP; Zhang J; Lei Y; Li YQ; Ma J
    Int J Cancer; 2018 Jun; 142(12):2558-2566. PubMed ID: 29377121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.